August 4, 2020
Leaders from across the health sector released a joint statement underlining the potential of the recently-published draft proposal for a European Partnership for Health Innovation, or Innovative Health Initiative (IHI), released by the European Commission.
The statement – which accounts for COCIR, EFPIA, EuropaBio, MedTech Europe and Vaccines Europe, all partners in the initiative – acknowledge...
July 30, 2020
D2C wellness and telehealth startup Hims & Hers is looking to cut down the time between medication orders and delivery for certain customers.
Thanks to a newly announced partnership, patients receiving virtual primary care services through Hims & Hers may choose to select Alto as their preferred pharmacy for prescription deliveries. They will have their orders fulfilled automatically ...
July 16, 2020
Retail pharmacy chain Walgreens has cut a new deal with DoorDash that will bring on-demand delivery of over-the-counter medications and other health, wellness and convenience products to consumers, the companies announced today.
Starting today, customers living in the Chicago, Atlanta and Denver areas can place orders for more than 2,300 items via the DoorDash app or website. The companies said...
July 16, 2020
Pharma giant Roche and its subsidiary Genentech have inked a deal with PicnicHealth, a startup that helps patients access and share their medical records.
The real-world evidence deal will allow the pharmaceutical companies to have access to PicnicHealth’s set of de-identified patient records in order to gain insights about certain diseases and treatments. Patients must first consent to their...
July 16, 2020
Jerusalem-based Teva Pharmaceuticals announced this week the U.S. launch of its ProAir Digihaler.
The sensor-laden albuterol dispenser requires a prescription, and is indicated for those aged four years or older with reversible obstructive airway diseases such as asthma and COPD, as well as for the prevention of exercise-induced bronchospasm (EIB) among this same group.
The device connects to a...
July 9, 2020
Pharma giant Otsuka is rolling out a new kidney focused platform called NephU that provides online resources about nephrology conditions and a place for clinicians to collaborate and share information amongst themselves, and with patients.
Users will be able to tap into an online library of resources that include video, audio, webinars and podcasts. According to the site, the “community”...
July 7, 2020
Novartis and respiratory health company Propeller Health, a ResMed subsidiary, have teamed up to co-package the latter’s digital health platform with the pharma giant’s new asthma medication Enerzair Breezhaler.
This news come shortly after the product landed European Commission clearance. The co-packaged product will be launching in the EU during 2020. However, it is not yet available in the U....
June 29, 2020
Editor's note: An earlier version of this story stated that Brainlab is based in Berlin, rather than Munich.
Level Ex, a Chicago startup that makes medical-training video games for doctors, has been acquired by Munich-based medical-technology company Brainlab, the companies announced today.
The companies did not disclose the terms of their deal, although Level Ex CEO Sam Glassenberg told...
June 25, 2020
Historically, women have been underrepresented in clinical trials, however, that paradigm is changing. This shift is mainly due to policy changes in the last three decades, but today many innovators are also seeing a role for tech to play in closing this gap.
This morning MobiHealthNews sat down with a panel at Women of Wearables’ FemTech Forum to moderate a discussion about the gender gap in...
June 24, 2020
FDA begins sharing patient's cancer drug experiences. The FDA's Oncology Center of Excellence has kicked off the first step of new pilot program that will increase the availability of patient-reported outcome data from cancer clinical trials. Project Patient Voice, as it's called, will start with making the data from a single trial accessible online while the agency solicits public feedback, but...